British Association of Dermatologists guidelines for the safe and effective prescribing of oral ciclosporin in dermatology 2018

Br J Dermatol. 2019 Jun;180(6):1312-1338. doi: 10.1111/bjd.17587. Epub 2019 Apr 7.

Authors

J Berth-Jones¹, L S Exton², E Ladoyanni³, M F Mohd Mustapa², V M Tebbs⁴, P D Yesudian⁵, N J Levell⁶

Affiliations

¹ Department of Dermatology, University Hospitals Coventry and Warwickshire NHS Trust, Coventry, CV2 2DX, U.K.
² British Association of Dermatologists, Willan House, London, W1T 5HQ, U.K.
³ Department of Dermatology, Dudley Group NHS Foundation Trust, Dudley, DY1 2HQ, U.K.
⁴ formerly of George Eliot Hospital, College Street, Nuneaton, CV10 7DJ, U.K.
⁵ Wrexham Maelor Hospital, Croesnewydd Road, Wrexham, LL13 7TD, U.K.
⁶ Dermatology Department, Norfolk and Norwich University Hospital, Colney Lane, Norwich, NR4 7UY, U.K.

PMID: 30653672
DOI: 10.1111/bjd.17587

No abstract available

Publication types

Practice Guideline

MeSH terms

Administration, Oral
Bone Demineralization, Pathologic / chemically induced
Child
Contraindications, Drug
Counseling
Cyclosporine / administration & dosage*
Cyclosporine / adverse effects
Cyclosporine / pharmacology
Dermatologic Agents / administration & dosage*
Dermatologic Agents / adverse effects
Dermatologic Agents / pharmacology
Drug Administration Routes
Drug Administration Schedule
Drug Eruptions / etiology
Drug Interactions
Drug Therapy, Combination
Female
Humans
Hyperlipidemias / chemically induced
Hypertension / chemically induced
Immunosuppressive Agents / administration & dosage*
Immunosuppressive Agents / adverse effects
Immunosuppressive Agents / pharmacology
Medical History Taking
Off-Label Use
Opportunistic Infections / chemically induced
Phototherapy / methods*
Physical Examination
Pregnancy
Skin Diseases / drug therapy*
Vaccination

Substances

Dermatologic Agents
Immunosuppressive Agents
Cyclosporine